İlKer Erden
Research Subjects
Research Interests
İlKer Erden has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Betul Demir
Department of Dermatology and Venereology, Faculty of Medicine, Fırat University, 23119 Elazığ, Türkiye
1 shared publication - Demet Cicek
Department of Dermatology, Firat University Hospital
1 shared publication - Esma Inan Yuksel
Department of Dermatology Firat University Hospital Elazig Turkey
1 shared publication - Mehmet Kalayci
Department of Medical Biochemistry, Elazig Education and Research Hospital, Elazig, Turkey
1 shared publication - Meltem Yardim
Faculty of Medicine, Basic Sciences, Department of Biochemistry, Necmettin Erbakan University, Konya, Türkiye
1 shared publication - Suleyman Aydin
Department of Medical Biochemistry, Faculty of Medicine, Fırat University, 23119 Elazığ, Türkiye
1 shared publication
Latest Publications
Investigation of serum and saliva dermcidin levels in patients with recurrent aphthous stomatitis and dermcidin analysis in salivary gland
Objective Recurrent aphthous stomatitis (RAS) is a common self-limiting oral mucosa disease. In this study, it was aimed to determine the dermcidin level in the serum and saliva of patients with RAS, the presence of dermcidin in the salivary gland and its role in the pathogenesis of RAS. Methods Thirty-one patients presenting with RAS and 30 control subjects participated in this study. Dermcidin levels in serum and saliva of patients and control group were studied in accordance with the working procedures specified in the catalogs of the human dermcidin ELISA kit. The presence of dermcidin in salivary glands was assessed by immunohistochemical analysis. Results A statistically significant difference was found when the mean salivary dermcidin levels (105.80 ± 80.14 ng/mL) of the RAS patients were compared with the mean salivary dermcidin levels (456.13 ± 354.59 ng/mL) of the control group (P=0.000). There was no statistically significant difference between the mean serum dermcidin levels (316.41 ± 784.55 ng/mL) of the RAS patient and those of (130.65 ± 179.75 ng/mL) the control group. Dermcidin immunoreactivity was observed in the parotid gland, submandibular gland and interlobular striated ducts. Conclusion The findings in this study showed that striated cells in salivary gland synthesized dermcidin. Low levels of dermcidin with antimicrobial properties in saliva were considered as a predisposing factor for RAS.
Investigation of serum and saliva dermcidin levels in patients with recurrent aphthous stomatitis and dermcidin analysis in salivary gland
Objective Recurrent aphthous stomatitis (RAS) is a common self-limiting oral mucosa disease. In this study, it was aimed to determine the dermcidin level in the serum and saliva of patients with RAS, the presence of dermcidin in the salivary gland and its role in the pathogenesis of RAS. Methods Thirty-one patients presenting with RAS and 30 control subjects participated in this study. Dermcidin levels in serum and saliva of patients and control group were studied in accordance with the working procedures specified in the catalogs of the human dermcidin ELISA kit. The presence of dermcidin in salivary glands was assessed by immunohistochemical analysis. Results A statistically significant difference was found when the mean salivary dermcidin levels (105.80 ± 80.14 ng/mL) of the RAS patients were compared with the mean salivary dermcidin levels (456.13 ± 354.59 ng/mL) of the control group (P=0.000). There was no statistically significant difference between the mean serum dermcidin levels (316.41 ± 784.55 ng/mL) of the RAS patient and those of (130.65 ± 179.75 ng/mL) the control group. Dermcidin immunoreactivity was observed in the parotid gland, submandibular gland and interlobular striated ducts. Conclusion The findings in this study showed that striated cells in salivary gland synthesized dermcidin. Low levels of dermcidin with antimicrobial properties in saliva were considered as a predisposing factor for RAS.